HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies

Journal of Neuroimmunology

Volumn 84, Issue 2, 1998, Pages 139-142

  Koffman, Boyd M ^a   Sivakumar, Kumaraswamy ^a   Simonis, Toni ^a   Stroncek, David ^a   Dalakas, Marinos C ^a  

^a NONE

Author keywords

HLA association; Immunogenetics; Inclusion body myositis

Indexed keywords

HLA ANTIGEN CLASS 2;

ADULT; AGED; ALLELE; ARTICLE; CLINICAL ARTICLE; DIFFERENTIAL DIAGNOSIS; FEMALE; GENE FREQUENCY; HAPLOTYPE; HLA SYSTEM; HUMAN; IMMUNOGENICITY; INCLUSION BODY MYOSITIS; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AGED; ALLELES; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE FREQUENCY; GENETIC DISEASES, INBORN; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; MYOSITIS, INCLUSION BODY;

EID: 0032522265     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00245-2     Document Type: Article

References (26)

1. Arahata K., Engel A.G. Monoclonal antibody analysis of mononuclear cells in myopathies. V: Identification and quantitation of T8+ cytotoxic and T8+ suppressor cells. Ann. Neurol. 23:1988;493-499.
2. Argov Z., Yarom R. 'Rimmed vacuole myopathy' sparing the quadriceps: a unique disorder in Iranian Jews. J. Neurol. Sci. 64:1984;33-43.
3. Arnett F.C., Goldstein R., Duuvic M., Reveille J.D. Major histocompatibility complex genes in systemic lupus erythematosus, Sjögren's syndrome, and polymyositis. Am. J. Med. 85:1988;38-41.
4. Bodmer J.G., Marsh S.G.E., Albert E.D., Bodmer W.F., Bontrop R.E., Charron D. Nomenclature for factors of the HLA system, 1995. Hum. Immunol. 43:1995;149-164.
5. Czaja A.J., Santrach P.J., Moore S.B. HLA-DQ association in Type 1 autoimmune hepatitis. Mayo Clin. Proc. 70:1995;1154-1160.
6. Dalakas M.C. Polymyositis, dermatomyositis, and inclusion body myositis. New Engl. J. Med. 325:1991;1487-1498.
7. Dawkins R.L., Christiansen F.T., Kay P.H., Garlepp M., McCluskey J., Hollingsworth P.M., Zilko P.J. Disease associations with complotypes, supratypes and haplotypes. Immunol. Rev. 70:1983;5-22.
8. Garlepp M.J., Laing B., Zilko P.J., Ollier W., Mastaglia F.L. HLA associations with inclusion body myositis. Clin. Exp. Immunol. 98:1994;40-45.
9. Hohlfeld R., Engel A.G. The immunology of muscle. Immunol. Today. 15:1994;269-274. Review.
10. Kelly H., McCann V.J., Kay P.H., Dawkins R.L. Susceptibility to IDDM is marked by MHC supratypes rather than individual alleles. Immunogenetics. 22:1985;643-651.
11. Koffman B.M., Rugiero M., Dalakas M.C. Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis. Muscle and Nerve. 21:1998;115-117.
12. Lee, T.D., 1990. Distribution of HLA antigens in North American Caucasians, North American Blacks and Orientals. In: Lee, J. (Ed.), The HLA System. Springer-Verlag, New York, pp. 141-178.
13. Lindberg C., Oldfors A., Tarkowski A. Restricted use of T-cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies. Eur. J. Immunol. 24:1994;2659-2663.
14. Lotz B.P., Engel A.G., Nishino H., Stevens J.C., Litchy W.J. Inclusion body myositis: observations in 40 patients. Brain. 112:1989;727-747.
15. Love L.A., Leff R.L., Fraser D.D., Targoff I.N., Dalakas M., Plotz P.H., Miller F.W. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine. 70:1991;360-374.
16. Mikol, J., Engel, A.G., 1994. Inclusion body myositis. In: Engel, A.G., Franzini-Armstrong, C. (Eds.), Myology. McGraw-Hill, New York, pp. 1384-1398.
17. Mitrani-Rosenbaum S., Argov Z., Blumenfeld A., Seidman C.E., Seidman J.G. Hereditary inclusion body myopathy maps to chromosome 9p1-q1. Hum. Mol. Genet. 5:1996;159-163.
18. Neville H.E., Baumbach L.L., Ringel S.P., Russo L.S. Jr., Sujansky E., Garcia C.A. Familial inclusion body myositis: evidence for autosomal dominant inheritance. Neurology. 42:1992;897-902.
19. O'Hanlon T.P., Dalakas M.C., Plotz P.H., Miller F.W. The alpha beta T-cell receptor repertoire in inclusion body myositis: diverse patterns of gene expression by muscle-infiltrating lymphocytes. J. Autoimmun. 7:1994;321-333.
20. Park, M.S., Tonai, R., 1992. Phenotype frequencies of the class II (DR, DQ) DNA alleles by the pattern of sequence-specific primer mixtures (SSPM) in four different populations and probable haplotypes between DRB1 allele and DQB1 allele. In: Terasaki, Cecka (Eds.), Clinical Transplants. UCLA Tissue Typing Laboratory. California, pp. 475-500.
21. Reinertsen J.L., Klippel J.H., Johnson A.H., Steinberg A.D., Decker J.L., Mann D.L. B-lymphocyte alloantigens associated with systemic lupus erythematosus. New Engl. J. Med. 299:1978;515-518.
22. Sadeh M., Gadoth N., Hadar H., Ben-David E. Vacuolar myopathy sparing the quadriceps. Brain. 116:1993;217-232.
23. Satsangi J., Welsh K.I., Bunce M., Julier C., Farrant J.M., Bell J.I., Jewell D.P. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet. 347:1996;1212-1217.
24. Sekul E., Dalakas M.C. Inclusion body myositis: new concepts. Semin. Neurol. 13:1993;256-263. Review.
25. Sivakumar K., Dalakas M.C. The spectrum of familial inclusion body myopathies in 13 families and a description of a quadriceps-sparing phenotype in non-Iranian Jews. Neurology. 47:1996;977-984.
26. Sivakumar K., Semino-Mora C., Dalakas M.C. An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis: studies in 3 families. Brain. 120:1997;653-661.